Archive for the ‘misconduct investigations’ Category
Karl-Henrik Grinnemo was worried. The doctor and clinical researcher at the Karolinska Institute was working with a high-profile surgeon who was performing a potentially life-saving procedure on patients, but Grinnemo saw that the patients weren’t doing very well. So in 2013, Grinnemo and three other doctors raised concerns about the work of Paolo Macchiarini. The surgeon initially fought back, and accused Grinnemo of misconduct. KI sided with the star surgeon, and found Grinnemo guilty of “carelessness” in a grant application to the Swedish Research Council, including plagiarism. Readers should by now know how the story ends – Macchiarini’s work has since been largely discredited. Recently, to clear his name, Grinnemo asked authorities to take a second look at his case – and he has been exonerated. We talked to him about the last few tumultuous years.
Retraction Watch: How does the story begin?
The president of a top university in Taiwan has announced he will resign from his post at the end of his first term in June.
President Pan-chyr Yang of National Taiwan University (NTU) has opted not to seek a second term as president given two recent investigations — one which concluded last month and one which is ongoing — into allegations of misconduct in papers he co-authored.
Despite being cleared of misconduct in the investigation conducted by his university, Yang felt that the scandal had left a stain on NTU’s reputation, which he hoped to restore by stepping down as president. Here’s more from Focus Taiwan: Read the rest of this entry »
An earth science journal has asked an editor to resign after it was revealed he had been manipulating citations at multiple journals.
Artemi Cerdà had already agreed to step down temporarily from Land Degradation & Development after the publisher, Wiley, was alerted that Cerdà had resigned from other journals for citation manipulation. In a new statement, the journal announces that Cerdà’s resignation has become permanent.
Here’s the entire statement:
Ask and ye shall receive: A journal has retracted a 2014 paper by Paolo Macchiarini, upon request from the Karolinska Institutet (KI).
The latest news is only one step in a long-running saga about former star surgeon Macchiarini, who was dismissed from KI last year. To read more, check out our timeline.
KI announced it was asking the journal to pull the paper late last year, after concluding that four authors — including Macchiarini — were guilty of scientific misconduct. The paper had already been flagged by the journal with an expression of concern, noting the data presented in the paper may not be “fully representative” of the experiments.
Today, the journal issued a retraction notice, saying the authors wanted to retract the paper. All of the authors who could be reached have agreed to the retraction, including Macchiarini.
Here’s more from the notice:
Despite taking some serious hits, a 2006 letter in Nature isn’t going anywhere.
Years ago, a university committee determined that two figures in the letter had been falsified. The journal chose to correct the paper, rather than retract it — and then, the next year, published a correction of that correction due to “an error in the production process.” To round it out, in June of last year, Nature published a rebuttal from a separate research group, who had failed to replicate the letter’s results.
Still, the first author told us there are no plans to retract the paper, since the follow up experiments published in the corrections confirmed the paper’s conclusions.
Two countries have recently announced plans to learn more about research misconduct, with the goal of preventing it from happening in the first place.
In Japan, the effort takes the form of a joint study group among six universities, which will interview researchers who have engaged in misconduct to discover patterns and common factors for their wrongdoing. In Taiwan, the government recently announced plans to establish an Office of Research Integrity, based on the version in the U.S., to investigate alleged cases of misconduct.
Here’s more about the new Taiwan office, from the Taipei Times:
Neuroscientist Stanley Rapoport hasn’t had much luck with his co-authors.
Recently, we’ve reported on multiple retractions of papers co-authored by Rapoport after three different first authors were found to have committed misconduct. Now, the fallout from one of those cases had led to four more retractions, bringing Rapoport’s total to 12.
The latest batch of retractions stem from the actions of Jagadeesh Rao.
Here’s the first notice, issued by Psychopharmacology:
The editors of an anesthesiology journal have retracted a paper about predicting how patients will respond to a procedure, after the results of an investigation cast doubt on the validity and originality of the work.
According to the retraction notice, the editors became concerned about the validity of the data and conducted an investigation, which found irregularities, “including misrepresentation of results.” Because the authors could not provide adequate evidence to assuage these concerns, the editors decided to retract the paper.
The paper — about which facial muscles best predict if a patient is ready to be intubated — had already been flagged on F1000: A few years ago, two anesthesiologists from Florida commented that they found the article “confusing,” and felt that the authors “did not prove their hypothesis.”
Here’s the retraction notice for “Comparison of four facial muscles, orbicularis oculi, corrugator supercilii, masseter or mylohyoid, as best predictor of good conditions for intubation: A randomised blinded trial,” published in the European Journal of Anaesthesiology in 2013 and cited once: Read the rest of this entry »
The timing was tight, but Sergio Gonzalez had done it. Gonzalez, a postdoctoral researcher at the Institute for Neurosciences of Montpellier (INSERM) in France, had a paper accepted in a top journal by the end of 2015, just in time to apply for a small number of highly sought-after permanent research positions that open up in France each year.
If Gonzalez had missed the January deadline for this system of advancement, known as concours, he would have had to wait until the following cycle to apply.
Once his paper was accepted by the Journal of Clinical Investigation, Gonzalez could breathe a sigh of relief. He began being invited to interviews. But then, a comment showed up at PubPeer.
Dmitri Lapotko, a Belarusian researcher with a background in laser weaponry, made a name for himself at Rice University in Houston, where he studied the use of nanotechnology to diagnose and treat human diseases. That work earned him significant press coverage, including stories in the New York Times and Science.
But that nanobubble may be bursting. The journal Theranostics has retracted a 2011 paper on which Lapotko is the last and corresponding author, citing questions over data falsification. What’s more, another journal has warned readers there may be a problem with a figure in a 2012 paper on which Lapotko is listed as last author.
Lapotko has since left Rice for Masimo Corp., a developer of monitoring devices for patients in the operating room.
According to the Theranostics notice: